A Study to Determine Eligibility for CAH-301 (A Study of Gene Therapy for Classic Congenital Adrenal Hyperplasia (CAH) [NCT04783181])

Clinical trial NCT05101902 · COMPLETED

Trial details

NCT number: NCT05101902
Sponsor: Adrenas Therapeutics Inc
Status: COMPLETED
Study type: OBSERVATIONAL

Congenital Adrenal Hyperplasia

Start date: 2021-07-01
Primary completion: 2024-08-07
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.